| flutamide / Generic mfg. |
NCT00003323: Hormone Therapy in Treating Patients With Prostate Cancer |
|
|
| Completed | 2 | 101 | US | finasteride, flutamide, quality-of-life assessment | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Prostate Cancer, Sexual Dysfunction and Infertility | 05/02 | 03/10 | | |
NCT00001266: A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma |
|
|
| Completed | 2 | 70 | US | Suramin | National Cancer Institute (NCI) | Prostatic Neoplasm | | 08/03 | | |
NCT00002889: Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer |
|
|
| Completed | 2 | 180 | US | flutamide, goserelin, leuprolide acetate, low-LET photon therapy | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Prostate Cancer | 01/04 | 06/09 | | |
NCT00817739: Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c |
|
|
| Completed | 2 | 341 | Europe | Leuprorelin, Flutamide | Takeda | Prostatic Neoplasms | 09/05 | 12/08 | | |
NCT00006214: Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate |
|
|
| Completed | 2 | 63 | US, Canada | flutamide, placebo | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Prostate Cancer | 07/06 | 07/06 | | |
NCT00003124: Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer |
|
|
| Completed | 2 | 105 | US | flutamide, leuprolide acetate, radiation therapy | Herbert Irving Comprehensive Cancer Center, National Cancer Institute (NCI) | Prostate Cancer | | 01/07 | | |
NCT00028769: S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer |
|
|
| Completed | 2 | 41 | US | bicalutamide, estramustine, estramustine phosphate sodium, etoposide, flutamide, goserelin, leuprolide, leuprolide acetate, nilutamide, paclitaxel | Southwest Oncology Group, National Cancer Institute (NCI) | Prostate Cancer | 06/10 | 07/11 | | |
NCT00283803: Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer |
|
|
| Completed | 2 | 32 | US | Exisulind, Aptosyn, luteinizing hormone-releasing hormone (LHRH) agonist, Lupron, Zoladex, Antiandrogen, Eulexin, Casodex | University of Washington, OSI Pharmaceuticals | Prostate Cancer | 10/11 | 10/11 | | |
NCT00223665: Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer |
|
|
| Completed | 2 | 102 | US | Flutamide, Eulexin, Leuprolide Acetate, Lupron Depot, Eligard, Lupron | University of Washington, Sanofi | Prostate Cancer | 09/12 | 09/12 | | |
NCT00003517: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer |
|
|
| Withdrawn | 2 | 0 | US | antineoplaston A10, antineoplaston AS2-1, bicalutamide, flutamide, leuprolide acetate, alternative product therapy, antiandrogen therapy, biological therapy, biologically based therapies, cancer prevention intervention, complementary and alternative therapy, differentiation therapy, endocrine therapy, hormone therapy | Burzynski Research Institute | Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer, Recurrent Prostate Cancer | | | | |
NCT00528866: Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy |
|
|
| Completed | 2 | 80 | Canada, US | bicalutamide, docetaxel, flutamide, LHRH agonist, 3-dimensional conformal radiation therapy, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI), NRG Oncology | Prostate Cancer | 12/13 | 05/18 | | |
NCT02341404 / 2011-001137-16: A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer |
|
|
| Completed | 2 | 23 | Europe | 2-hydroxyflutamide (2-HOF), Liproca Depot | Lidds AB, Uppsala University | Prostate Cancer | 05/15 | 05/15 | | |
NCT00450463: Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer |
|
|
| Completed | 2 | 64 | US | Sargramostim (GM-CSF, Leukine), GM-CSF, Flutamide (Eulexin), Eulexin, PROSTVAC-F/ TRICOM, PROSTVAC-F (rilimogene galvacirepvec/rilimogene glafolivec)/TRICOM (triad of costimulatory molecules, PROSTVAC-V/TRICOM | National Cancer Institute (NCI) | Prostate Cancer | 04/17 | 06/17 | | |
